Forums before death by AOL, social media and spammers... "We can't have nice things"
|    sci.med.psychobiology    |    Dialog and news in psychiatry and psycho    |    4,734 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 4,322 of 4,734    |
|    =?UTF-8?B?4oqZ77y/4oqZ?= to All    |
|    =?UTF-8?Q?Memory_loss_not_enough_to_diag    |
|    04 Dec 16 20:40:49    |
      From: mha23x@gmail.com              Memory loss not enough to diagnose Alzheimer’s       04       Nov, 2016              Memory loss not enough to diagnose Alzheimer’s        Alzheimers       Relying on clinical symptoms of memory loss to diagnose Alzheimer’s disease       may miss other forms of dementia caused by Alzheimer’s that don’t       initially affect memory, reports a new study published in the journal       Neurology.              There is more than one kind of Alzheimer’s disease. Alzheimer’s can cause       language problems, disrupt an individual’s behavior, personality and       judgment or even affect someone’s concept of where objects are in space. If       it affects personality, it        may cause lack of inhibition.              This all depends on what part of the brain it attacks. A definitive diagnosis       can only be achieved with an autopsy. Emerging evidence suggests an amyloid       PET scan, an imaging test that tracks the presence of amyloid — an abnormal       protein whose        accumulation in the brain is a hallmark of Alzheimer’s — may be used       during life to determine the likelihood of Alzheimer’s disease pathology.              In the study, the authors identified the clinical features of individuals with       primary progressive aphasia (PPA), a rare dementia that causes progressive       declines in language abilities due to Alzheimer’s disease. Early on in PPA,       memory and other        thinking abilities are relatively intact.              PPA can be caused either by Alzheimer’s disease or another neurodegenerative       disease family called frontotemporal lobar degeneration. The presence of       Alzheimer’s disease was assessed in this study by amyloid PET imaging or       confirmed by autopsy.              The study demonstrates that knowing an individual’s clinical symptoms       isn’t sufficient to determine whether someone has PPA due to Alzheimer’s       disease or another type of neurodegenerative disease. Therefore, the authors       say, biomarkers, such as        amyloid PET imaging, are necessary to identify the neuropathological cause.              Paper: “Aphasic variant of Alzheimer disease”       Reprinted from materials provided by Northwestern University.              GO TO JPND NEWS       GO TO RESEARCH NEWS       GO TO INTERVIEWS       Newsletter / RSS Signup              SIGNUP HERE              Categories              JPND News       JPND Press Releases       JPND Progress       JPND Publications       Research News (General)       Tags              AgingAlzheimer'sAlzheimer's diseaseBrainBrain researchDementiane       rodegenerationParkinson'sParkinson's DiseaseResearch       Archives              ► 2016       ► 2015       ► 2014       ► 2013       ► 2012       ► 2011       ► 2010       Search                      footer-logo              The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the       largest global research initiative aimed at tackling the challenge of       neurodegenerative diseases, in particular Alzheimer’s. Learn More                     RECENT JPND NEWS              Report of the second OECD Lausanne Workshop now available       Report on survey of 2015 JPco-fuND call applicants       Joint Transnational Call for Research Proposals – Pre-announcement       Achievements of Slovak scientists presented in Brussels       MeetingDem progress update: JPND project brings Dutch model for dementia care       to Italy, Poland and the UK       NAVIGATION              Home       About JPND       Major Activities       Open Calls       Supported Projects       News & Media       Research Database       Stakeholder Database Entry       Sitemap       CONTACT US              General enquiries: secretariat@jpnd.eu                       This initiative has received funding from the European Union’s Horizon 2020       research and innovation programme under grant agreements No 643417 and No       681043.              EU emblem              ©2014 JPND Research       This site uses cookiesNo problemMore info                            http://www.neurodegenerationresearch.eu/2016/11/memory-loss-not-       nough-to-diagnose-alzheimers/              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca